Drugs used to treat breast-cancer patients can cause premature ovarian failure. In fact, many women undergoing chemotherapy for breast-cancer freeze their eggs or embryos before treatment if they want to have children in the future.
A promising study showed that women, who underwent chemotherapy with the hormone suppressor Goserelin, had lower rates of ovarian failure. In addition the women had higher rates of pregnancies and births than those who did not receive the hormone treatment.
However, patients should view the results with some caution because Goserelin does not protect ovarian failure in breast-cancer cases where women are positive for certain hormone receptors. Furthermore, the study enrolled only 250 women despite an initial goal of 400.
Read more here.